Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dDhiCfbwocevzulpjhmo

May 1, 2012News for the biotech, medical device, drug and food regulatory profession

  Drugs & Biologics 
  • Pozen faces regulatory hurdle for aspirin-omeprazole combo
    The FDA suggested that Pozen seek approval for combination aspirin product PA32540 at a lower dose, the company said in a regulatory filing. The market for PA32540 could be limited without a lower dose because the FDA might restrict a higher dose to patients who underwent surgery for a coronary artery bypass graft. MedCityNews.com (4/30) Email this Story
  • Court rules for Mylan and Impax in Doryx patent case
    U.S. District Judge William Martini ruled that Mylan and Impax Laboratories did not infringe Warner Chilcott's patent for antibiotic Doryx that is set to expire in 2022. The ruling forces Warner Chilcott to book an impairment charge of $90 million to $108 million, the firm said. Bloomberg (4/30) Email this Story
  Global Focus 
  Food & Dietary Supplements 
  • USDA inspector reviews FSIS humane-handling enforcement
    The USDA's Office of Inspector General has issued a positive report on how the Food Safety and Inspection Service's review of appeals from the industry regarding its humane-handling enforcement actions. "As OIG noted, FSIS has taken many steps to improve its inspectors' understanding of humane handling requirements and the tools they have to ensure the humane handling of livestock," says Undersecretary for Food Safety Elisabeth Hagen in a news release. FoodSafetyNews.com (5/1) Email this Story
  • Other News
  Featured Content 
 

  Medical Devices 
  • 5 governors call for repeal of medical device tax
    The governors of Pennsylvania, Indiana, South Carolina, Virginia and Wisconsin -- five states with large clusters of medtech companies -- wrote a letter urging Senate and House leaders to strike down the 2.3% medical device tax. "We believe that this tax could harm U.S. global competitiveness, stunt medical innovation and result in the loss of 10s of thousands of good-paying jobs," the governors wrote. MassDevice.com (Boston) (4/30) Email this Story
  • Nephros wins FDA nod for chronic renal failure device
    The FDA has granted Nephros 510(k) clearance for its Hemodiafiltration system, which is used to help treat patients with chronic renal failure. The device features the company's OLpur MD220 Hemodiafilter and OLpur H2H Hemodiafiltration module. Reuters (4/30) Email this Story
  Tobacco 
  • Australia plans joint legal action against Big Tobacco
    Australia's Minister for Health Tanya Plibersek will ask for legal advice on a proposed nationwide class-action suit against Big Tobacco to retrieve costs of smoking-related illnesses. Tasmania Health Minister Michelle O'Byrne said governments should not stop finding ways to limit smoking's impact on the health system. The Australian (subscription required) (5/1) Email this Story
  FDLI Items 
  • Save $100 on Introduction to Medical Device Law in Palo Alto, Calif., in June
      
    Whether you are a new professional in the medical device industry or seasoned regulatory affairs or legal professional needing a refresher on current FDA medical device regulatory developments, you will benefit from attending this in-depth, interactive two-day course. Attendees will hear from experts who will review the essential elements of medical device regulation. Register today to save $100. Early-bird discount Email this Story
  • theLINK: A Comprehensive FDA Directory -- Save $250 on your online subscription
     
    • Updated: Accurate and updated organizational charts -- print and share with clients and colleagues.
    • Organized: 10,000 contacts at your finger tips -- theLINK will help you prepare for meetings and prepare your clients -- giving you an edge over competitors.
    • Accessible: The online version is continuously updated, and available anywhere.
    • Detailed: theLINK includes expanded background information on many employees, including prior experience as well as speaking engagement.
    Learn more and save up to $250 on your new subscription. Email this Story
Learn more about FDLI ->About FDLI  |  Join FDLI  |  Conferences  |  Publications

 
Position TitleCompany NameLocation
CounselVerto Solutions, LLCWashington DC, DC
Assistant General Counsel, US Promotional & Regulatory Compliance Surgical/Pharma Alcon LabsFort Worth, TX
Associate General CounselConsumer Healthcare Products AssociationWashington, DC
Junior to Mid-Level FDA & Healthcare AssociateMorgan LewisWashington, DC
Click here to view more job listings.

  SmartQuote 
Between two evils, I always pick the one I never tried before."
--Mae West,
American actress


Email this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent FDLI SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information